RMD Dec 2024 155.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

33.06

0.00

(0.00%)

As of 02:42PM EDT. Market open.

Loading interactive chart…

Zacks
Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
Zacks
Maravai (MRVI) Advances in RNA Research With New Collaboration
Per Maravai LifeSciences (MRVI) management, this development by TriLink is set to advance nucleic acid-based therapies.
Zacks
Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue?
Investors are optimistic about Haemonetics (HAE) led by its strategic focus on establishing leading positions in high-growth markets to generate solid financial returns.